Sugi Predict

Sugi Predict / Compounds / SCHEMBL811965

SCHEMBL811965

SCHEMBL811965

CCOC(=O)OC1=C(c2c(C)cc(-c3ccc(Cl)cc3)cc2C)C(=O)CC12CCCCC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ MAPT P10636 3/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GAA P10253 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ ALPL P05186 1/20 0.32
▸ FAAH O00519 1/20 0.32
▸ CACNB4 O00305 1/20 0.32
▸ CACNA1A O00555 1/20 0.32
▸ CACNA1G O43497 1/20 0.32
▸ CACNG3 O60359 1/20 0.32
▸ CACNA1F O60840 1/20 0.32
▸ CACNA1H O95180 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ CACNB3 P54284 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812048 0.82 LMNA (0.38) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL811937 0.81 MEN1 (0.34) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL812271 0.80 ACACB (0.37) ALDH1A1NPSR1ALPL
SCHEMBL811968 0.78 LMNA (0.47) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL811909 0.75 ACACB (0.38) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL13359405 0.74 LMNA (0.36) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL2759798 0.72 ACACB (0.42) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL13097280 0.72 DRD2 (0.35) SMN1; SMN2KDM4EALDH1A1NPC1
SCHEMBL19139445 0.69 ALDH1A1 (0.31) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL2349711 0.69 ACACB (0.34) LMNAMEN1KMT2AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058210-B2 Arylphenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2011-11-15 — — US disclosed
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 — — US disclosed
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 — — US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 — — US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 — — US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 — — US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 — — US disclosed
US-7288676-B2 Arylphenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols KCNE1, DDT, KCNQ3 LMNA 2176/4885MEN1 4843/4885KMT2A 660/4885
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS KCNE1, DDT, KCNQ3 LMNA 2176/4885MEN1 4843/4885KMT2A 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.